214 related articles for article (PubMed ID: 3874598)
1. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
[TBL] [Abstract][Full Text] [Related]
2. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
Angehrn P
Chemotherapy; 1985; 31(6):440-50. PubMed ID: 3935396
[TBL] [Abstract][Full Text] [Related]
4. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
Le Noc P; Croize J; Le Noc D
Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
[TBL] [Abstract][Full Text] [Related]
5. In-vitro evaluation of carumonam (Ro 17-2301).
Stobberingh EE; Houben AW; van Boven CP
J Antimicrob Chemother; 1986 Sep; 18(3):345-50. PubMed ID: 3490467
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
Neu HC; Chin NX; Neu NM
Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
Soussy CJ; Le Van Thoi J; Duval JR
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antibacterial activity of AMA-1080.
Matsuda K; Hamana Y; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1985 Nov; 16(5):539-47. PubMed ID: 3878360
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity and beta-lactamase stability of carumonam.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.
Nakao M; Kondo M; Imada A
J Antimicrob Chemother; 1986 Apr; 17(4):433-9. PubMed ID: 3086273
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
16. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
Labia R; Morand A; Pitton JS; Philippin JL; Fournier P
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
[TBL] [Abstract][Full Text] [Related]
19. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
Raimondi A; Mattina R; Cocuzza CE
Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
